CCK-8 assays were performed to assess the impact of CDRs silencing on cell growth, which demonstrated a significant tumor cell growth inhibition effect in both C4-2 and PC3 cells regardless of the AR signaling activity (Fig. 4K, L). Here, AR is linked to neoplasm.